Fig. 8.
A Adapalene and ranolazine prolonged the clotting time. ap < 0.05 compared to control, bp < 0.05 compared to 0.25 M CaCl2 + 5 μM ADA, cp < 0.05 compared to 0.25 M CaCl2 + 10 μM ADA, dp < 0.05 compared to 0.25 M CaCl2 + 20 μM ADA, ep < 0.05 compared to 0.25 M CaCl2 + 5 μM RAN, fp < 0.05 compared to 0.25 M CaCl2 + 10 μM RAN, and gp < 0.05 compared to 0.25 M CaCl2 + 20 μM RAN in their respective groups. All values are represented in the form of mean ± SD (n = 4). (One-way ANOVA followed by Tukey’s multiple comparison post hoc test). B Adapalene and ranolazine alleviated the formation of dense clots after 2 h. [A. control, B. 0.25 M CaCl2 + ADA 5 μM, C. 0.25 M CaCl2 + ADA 10 μM, D. 0.25 M CaCl2 + ADA 20 μM, E. 0.25 M CaCl2 + RAN 5 μM, F. 0.25 M CaCl2 + RAN 10 μM, G. 0.25 M CaCl2 + RAN 20 μM, and H. 0.25 M CaCl2 + CLOP 30 μM]
